Bluejay Investor Presentation Deck

●●● IL-6 is Following a Well-Established Clinical Testing Pathway Studies will document Symphony performance versus standard of care Initial Clinical Testing Plan Completed in Q3:22, on track with Company plans Milestone Clinical Testing Sites bluejay DIAGNOSTICS UT Southwestern Medical Center. Zale Lipshy Pavilion Hospital Initial Testing Program at UT Southwestern Medical Center File FDA Pre-submission application Clinical Trials File a de novo Marketing Application with the FDA William P. Clements Jr. University Hospital Parkland Target Timing Q4:2021: Complete January 2022: Complete Q1-Q3:2022: Complete YE:22 Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | September 2022 11

View entire presentation